Related Experiment Videos
Antioxidants, statins, and atherosclerosis.
1Weill Medical College of Cornell University, New York, New York 10021, USA. amg_editorial@med.cornell.edu
Journal of the American College of Cardiology
|April 8, 2003
Summary
Antioxidant use for coronary prevention shows inconsistent results, unlike statins. Further research is needed to clarify antioxidant study limitations before widespread clinical adoption.
Area of Science:
- Cardiovascular Research
- Oxidative Stress Biology
- Atherosclerosis Pathogenesis
Background:
- Lipoprotein oxidation is implicated in atherosclerosis development.
- Antioxidant efficacy in clinical trials for coronary events is inconsistent.
- Statins demonstrate clear benefits in lipid modification and risk reduction.
Purpose of the Study:
- To evaluate the role of lipoprotein oxidation in atherosclerosis.
- To analyze the limitations of current antioxidant studies and agents.
- To provide recommendations for coronary event risk reduction.
Main Methods:
- Review of existing research on lipoprotein oxidation and atherosclerosis.
- Analysis of clinical trial data for antioxidant interventions.
- Comparison of antioxidant strategies with lipid-modifying therapies like statins.
Main Results:
- Lipoprotein oxidation's role in atherogenesis is biologically plausible but clinically unproven by antioxidants.
- Antioxidant interventions have yielded inconsistent effects on coronary end points.
- Statins and Mediterranean diet modifications show proven efficacy in reducing coronary risk.
Conclusions:
- Current evidence does not support the use of antioxidants for coronary prevention.
- Limitations in antioxidant studies and agents need clarification.
- Prioritizing proven lipid modification strategies like statins and dietary changes is recommended for clinical practice.